Psych Congress and NEI Congress 2024: Alkermes highlights key data on psychiatric treatments and narcolepsy research
Alkermes announced the presentation of research related to Lybalvi (olanzapine and samidorphan) and Aristada (aripiprazole lauroxil), the company’s commercial products in psychiatry, and ALKS 2680, an investigational medicine… read more.
